Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10018553HBVENSG00000171560.18protein_codingFGANoNo2243P02671
TVIS10005139HBVENSG00000171560.18protein_codingFGANoNo2243P02671
TVIS10017708HBVENSG00000171560.18protein_codingFGANoNo2243P02671
TVIS10017489HBVENSG00000171560.18protein_codingFGANoNo2243P02671
TVIS10017490HBVENSG00000171560.18protein_codingFGANoNo2243P02671
TVIS10005140HBVENSG00000171560.18protein_codingFGANoNo2243P02671
TVIS10005141HBVENSG00000171560.18protein_codingFGANoNo2243P02671
TVIS10008153HBVENSG00000171560.18protein_codingFGANoNo2243P02671
TVIS10008154HBVENSG00000171560.18protein_codingFGANoNo2243P02671
TVIS10025297HBVENSG00000171560.18protein_codingFGANoNo2243P02671
TCGA Plot Options
Drug Information
GeneFGA
DrugBank IDDB00015
Drug NameReteplase
Target IDBE0000538
UniProt IDP02671
Regulation Type
PubMed IDs18673235; 19436656; 17963464
CitationsLongstaff C, Williams S, Thelwell C: Fibrin binding and the regulation of plasminogen activators during thrombolytic therapy. Cardiovasc Hematol Agents Med Chem. 2008 Jul;6(3):212-23.@@Melandri G, Vagnarelli F, Calabrese D, Semprini F, Nanni S, Branzi A: Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction. Vasc Health Risk Manag. 2009;5(1):249-56. Epub 2009 Apr 8.@@Hilleman DE, Tsikouris JP, Seals AA, Marmur JD: Fibrinolytic agents for the management of ST-segment elevation myocardial infarction. Pharmacotherapy. 2007 Nov;27(11):1558-70.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
PathwaysReteplase Action Pathway
PharmGKBPA164743728
ChEMBLCHEMBL2107885